UNIVERSITY OF WASHINGTON
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Phase 1
Completed
- Conditions
- Recurrent Verrucous Carcinoma of the Oral CavityTongue CancerRecurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the NasopharynxStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Squamous Cell Carcinoma of the OropharynxStage IVB Verrucous Carcinoma of the LarynxStage IVC Verrucous Carcinoma of the Oral CavityMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- Interventions
- Drug: TLR8 agonist VTX-2337Biological: cetuximabOther: laboratory biomarker analysisOther: pharmacogenomic studies
- First Posted Date
- 2011-04-13
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 13
- Registration Number
- NCT01334177
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose
Not Applicable
Completed
- Conditions
- Olfactory Disorder
- Interventions
- Other: saline nasal irrigation
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2013-12-12
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 41
- Registration Number
- NCT01332825
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
A Comparison of Specialized Versus Standard Compression After Saphenous Ablation
Not Applicable
- Conditions
- Varicose Veins
- Interventions
- Device: compression stockings (Sigvaris )Procedure: Compression stockings
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2011-05-02
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 20
- Registration Number
- NCT01332838
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Supporting Parents Program: Intervention for Families in CPS
Not Applicable
Completed
- Conditions
- Child AbuseChild Neglect
- Interventions
- Behavioral: Promoting First Relationships (PFR)Behavioral: Resource and Referral
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2018-06-07
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 270
- Registration Number
- NCT01332851
- Locations
- 🇺🇸
University of Washington, Family & Child Nursing, Seattle, Washington, United States
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
Not Applicable
Withdrawn
- Conditions
- Laryngo-pharyngeal Reflux
- First Posted Date
- 2011-04-04
- Last Posted Date
- 2017-07-05
- Lead Sponsor
- University of Washington
- Registration Number
- NCT01328392
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Levels of Raltegravir in the Female Genital Tissue
- First Posted Date
- 2011-04-01
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 10
- Registration Number
- NCT01327482
- Locations
- 🇺🇸
University of Washington, Clinical Research Center, Seattle, Washington, United States
PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate
Phase 2
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2011-04-01
- Last Posted Date
- 2017-10-05
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 62
- Registration Number
- NCT01327495
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer
Phase 1
Completed
- Conditions
- Stage III Ovarian Germ Cell TumorStage IV Ovarian Epithelial CancerStage III Ovarian Epithelial CancerStage IV Ovarian Germ Cell Tumor
- Interventions
- Biological: pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccineOther: laboratory biomarker analysis
- First Posted Date
- 2011-03-25
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 25
- Registration Number
- NCT01322802
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Pain Quality Study
Completed
- Conditions
- HeadacheLow Back PainFibromyalgia
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 307
- Registration Number
- NCT01321190
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women
Not Applicable
Completed
- Conditions
- Cervical Intraepithelial Neoplasia
- Interventions
- Procedure: Loop Electrosurgical Excision Procedure (LEEP)Procedure: Cryotherapy
- First Posted Date
- 2011-02-17
- Last Posted Date
- 2019-11-12
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 400
- Registration Number
- NCT01298596
- Locations
- 🇰🇪
Coptic Hospital, Nairobi, Kenya
© Copyright 2025. All Rights Reserved by MedPath